CareCloud, Inc. 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock - CCLDO STOCK NEWS

CareCloud announced a strategic partnership with KabaFusion to enhance KabaFusion's financial performance through improved revenue cycle management (RCM). This collaboration aims to streamline processes, reduce denials, and increase revenue capture. KabaFusion, a leader in specialty infusion services, specializes in therapies for patients with complex medical conditions, operating across 40 states with a dedicated team. CareCloud offers over 20 years of RCM expertise, providing technology-driven solutions to boost revenue and enhance patient experience. The partnership is seen as a significant opportunity to improve patient outcomes through innovation.

CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) announced cash dividends for its 11% Series A and 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock for March, April, and May 2023. This marks the 91st consecutive month of declared dividends since the Series A was launched in November 2015. The Series A dividend is $0.22917 per share, with a record date of March 31, 2023 and payment on April 17, 2023. The Series B dividend amount is $0.18229 with similar record and payment dates. The company continues to deliver consistent income to shareholders amidst market conditions.

CareCloud, Inc. reported its financial results for the year ended December 31, 2022, showcasing a revenue of $138.8 million, a slight decrease from $139.6 million in 2021. The company achieved a record GAAP net income of $5.4 million, up from $2.8 million the prior year. Adjusted net income was $16.3 million, or $1.07 per share, compared to $18.5 million in 2021. Despite a 13% revenue decline in Q4 2022 at $32.5 million, CareCloud's adjusted EBITDA was stable at $5.7 million. The company aims to build on its momentum in 2023 with new product launches.

CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO) has announced that its electronic health record (EHR) system, talkEHR, has been recognized by Google as Chrome Enterprise Recommended. This designation underscores CareCloud's focus on providing secure and reliable healthcare technology solutions.

talkEHR offers a cloud-based platform with features such as user-friendly interfaces, mobile access, and streamlined administrative tasks, enabling healthcare providers to enhance patient care and optimize workflow. The recognition from Google indicates that talkEHR meets strict security and operational standards, being compatible with the ChromeOS ecosystem.

CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) has been selected by Interstate Health Systems (IHS) to enhance their healthcare services for mobile employees and travelers, particularly truck drivers. IHS aims to create a nationwide healthcare network, addressing the unique needs of this underserved demographic. CareCloud's scalable platform will support IHS in managing patient records and optimizing administrative processes. The partnership includes CareCloud's Revenue Cycle Management (RCM) solution, Concierge, which utilizes AI to improve efficiency. This collaboration aims to revolutionize healthcare access for mobile individuals across the U.S.

CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) announced its participation at the AAOS 2023 Annual Meeting from March 7-11 in Las Vegas. The company will showcase its extensive healthcare technology solutions including practice management, electronic health records, and revenue cycle management. Karl Johnson highlighted the complexities of orthopaedic billing and CareCloud's capability in managing denied claims and providing prior authorization support. CareCloud's solutions like CareCloud Concierge, CareCloud Charts, and CareCloud Central aim to enhance operational efficiency and improve patient care, addressing the unique needs of healthcare providers.

CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) announced an increased secured line of credit from Silicon Valley Bank to $25 million, extended until October 13, 2025. This financial backing supports the company's efforts to grow and innovate within the digital healthcare sector. Since 2017, CareCloud has achieved a 34% compound annual growth rate in revenues and a 58% increase in adjusted EBITDA, while maintaining a virtually debt-free balance sheet. The funding is intended for general corporate purposes and growth initiatives as CareCloud continues to enhance its technology-enabled solutions.

CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) is set to showcase its digital health solutions at the American Telemedicine Association (ATA) Annual Conference from March 4-6, 2023. The company has established itself as a leader in digital health through the introduction of CareCloud Wellness, a suite designed to modernize healthcare delivery. This includes services for chronic care management and remote patient monitoring, allowing for proactive patient engagement. By integrating with CareCloud LIVE, a HIPAA-compliant telehealth platform, CareCloud aims to enhance patient outcomes and access to care while addressing traditional healthcare inefficiencies.

CareCloud (Nasdaq: CCLD, CCLDO, CCLDP) will announce its financial results for Q4 and the full year ending December 31, 2022, on March 2, 2023. The results will be released before the market opens, followed by a conference call for investors at 8:30 a.m. ET. The call will be accessible via a live webcast on the company’s investor relations page. A replay will be available shortly after the conclusion of the call. CareCloud continues to innovate in healthcare technology, assisting over 40,000 providers with solutions that enhance patient care and operational efficiency.